MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

por Ryan, J, Tivnan, A, Fay, J, Bryan, K, Meehan, M, Creevey, L, Lynch, J, Bray, I M, O'Meara, A, Davidoff, A M, Stallings, R L
Publicado 2012

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

por Ryan, J, Tivnan, A, Fay, J, Bryan, K, Meehan, M, Creevey, L, Lynch, J, Bray, I M, O'Meara, A, Tracey, L, Davidoff, A M, Stallings, R L
Publicado 2012

MYCN repression of Lifeguard/FAIM2 enhances neuroblastoma aggressiveness

por Planells-Ferrer, L, Urresti, J, Soriano, A, Reix, S, Murphy, D M, Ferreres, J C, Borràs, F, Gallego, S, Stallings, R L, Moubarak, R S, Segura, M F, Comella, J X
Publicado 2014